1. MP43-05 UPFRONT MRI IS THE NEW STANDARD, HAVE CONFIRMATORY BIOPSIES BECOME OBSOLETE?. (1st May 2022) Authors: Luiting, Henk; de Vos, Ivo Izaak; Remmers, Sebastiaan; Boevé, Egbert; Bangma, Chris; Valdagni, Riccardo; Chiu, Peter; Semjonow, Axel; Berge, Viktor; Tully, Karl; Rannikko, Antti; Staerman, Frédéric; Roobol, Monique Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MP59-03 A URINE-BASED MUTATION-METHYLATION ASSAY FOR THE SURVEILLANCE OF HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS. (May 2022) Authors: de Jong, Joep; de Jong, Florus; Ziel-van der Made, Angelique; Hagdorn, Ties; Boevé, Egbert; Roshani, Hossain; Oomens, Eric; Pelger, Rob; Steyerberg, Ewout; Boormans, Joost; Bangma, Chris; Zuiverloon, Tahlita; Zwarthoff, Ellen Journal: Journal of urology Issue: Volume 207(2022)Supplement 5 Page Start: e1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Unsafe testosterone-based dosing regimen of androgen deprivation therapy in patients with locally advanced or metastatic prostate cancer: a prematurely ended randomized controlled trial (MIDAS-trial). (3rd April 2021) Authors: Mulder, Midas B.; Birnie, Erwin; van Dijck – van Boetzelaer, Caroline; van de Geijn, Gert-Jan; Boevé, Egbert; Westerman, Elsbeth M.; Hamberg, Paul Journal: Acta oncologica Issue: Volume 60:Number 4(2021) Page Start: 539 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗